Gallwitz B, Schmidt W E, Schwarzhoff R, Creutzfeldt W
Department of Medicine, University of Göttingen, F.R.G.
Biochem Biophys Res Commun. 1990 Oct 15;172(1):268-75. doi: 10.1016/s0006-291x(05)80204-9.
Receptors for galanin, a neuropeptide inhibiting insulin release, have been described on RINm5F insulinoma cells. To characterize structural requirements for binding and biological activity of galanin, we studied binding and inhibition of hormone stimulated intracellular cAMP-production of N-terminal galanin fragments and -analogues in RINm5F cells. Half-maximal binding and potency were the same for all peptides used. Active peptides had the following rank of potency: galanin = galanin(1-22(23)Cys) greater than galanin(1-29(4)NLe) greater than galanin(1-18) greater than galanin(1-29(7)DAla) greater than galanin(1-29(2)DTrp4NLe7DAla) greater than galanin(1-29(2)DTrp). Galanin(3-29) was inactive. Therefore the first two amino acids of the galanin molecule with the indole side chain of the tryptophane residue in the right steric position are crucial for receptor binding.
甘丙肽是一种抑制胰岛素释放的神经肽,在RINm5F胰岛素瘤细胞上已发现其受体。为了确定甘丙肽结合和生物活性的结构要求,我们研究了RINm5F细胞中N端甘丙肽片段及类似物与激素刺激的细胞内cAMP产生的结合和抑制作用。所用的所有肽的半数最大结合力和效价相同。活性肽的效价顺序如下:甘丙肽=甘丙肽(1-22(23)半胱氨酸)>甘丙肽(1-29(4)正亮氨酸)>甘丙肽(1-18)>甘丙肽(1-29(7)丙氨酸)>甘丙肽(1-29(2)二对氯苯丙氨酸4-正亮氨酸7-丙氨酸)>甘丙肽(1-29(2)二对氯苯丙氨酸)。甘丙肽(3-29)无活性。因此,甘丙肽分子的前两个氨基酸以及色氨酸残基处于正确空间位置的吲哚侧链对于受体结合至关重要。